Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
We provide 1 form of Pralatrexate
Pralatrexate
146464-95-1
|
477.176
|
-0.112
Pralatrexate is an antimetabolite for the treatment of relapsed or refractory peripheral T-cell lymphoma. It is more efficiently retained in cancer cells than methotrexate. Pralatrexate competitively inhibits dihydrofolate reductase (DHFR) and thymidylate synthase.
10-propargyl-10-deazaaminopterin | 10-propargyl-10-deazaminopterin | PDX | folotyn | pralatrexate
Pralatrexate is an antimetabolite for the treatment of relapsed or refractory peripheral T-cell lymphoma. It is more efficiently retained in cancer cells than methotrexate. Pralatrexate competitively inhibits dihydrofolate reductase (DHFR) and thymidylate synthase.
10-propargyl-10-deazaaminopterin | 10-propargyl-10-deazaminopterin | PDX | folotyn | pralatrexate
$80/5 mg
(EBC)
1
We provide 0 compound for Pralatrexate